Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-24-008858
Filing Date
2024-08-15
Accepted
2024-08-15 14:56:01
Documents
19

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2168058
2 filename2.htm EX-10.6 490250
3 GRAPHIC g769642g02g02.jpg GRAPHIC 216927
4 GRAPHIC g769642g05f43.jpg GRAPHIC 601719
5 GRAPHIC g769642g30x67.jpg GRAPHIC 36350
6 GRAPHIC g769642g31l38.jpg GRAPHIC 116948
7 GRAPHIC g769642g36i96.jpg GRAPHIC 157122
8 GRAPHIC g769642g55f74.jpg GRAPHIC 58099
9 GRAPHIC g769642g62f25.jpg GRAPHIC 64074
10 GRAPHIC g769642g66t55.jpg GRAPHIC 32846
11 GRAPHIC g769642g72h13.jpg GRAPHIC 35890
12 GRAPHIC g769642g72u41.jpg GRAPHIC 29072
13 GRAPHIC g769642g76l04.jpg GRAPHIC 54832
14 GRAPHIC g769642g77q77.jpg GRAPHIC 33838
15 GRAPHIC g769642g81q05.jpg GRAPHIC 40409
16 GRAPHIC g769642g94f07.jpg GRAPHIC 97834
17 GRAPHIC g769642g96l94.jpg GRAPHIC 67135
18 GRAPHIC g769642g98g45.jpg GRAPHIC 43304
19 GRAPHIC g769642g98o36.jpg GRAPHIC 31282
  Complete submission text file 0000950123-24-008858.txt   5010360
Mailing Address 171 OYSTER POINT BOULEVARD, SUITE 300 SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BOULEVARD, SUITE 300 SAN FRANCISCO CA 94080 6508505070
Maze Therapeutics, Inc. (Filer) CIK: 0001842295 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-07295 | Film No.: 241211855
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)